Codon
JANUARY 21, 2024
Today, refined versions of these human challenge studies have become standard practice in testing vaccines for vector-borne diseases (e.g., Human challenge trials were an indispensable part of the development of the malaria vaccine, R21/Matrix-M, endorsed by the World Health Organization last October.
The Pharma Data
DECEMBER 14, 2020
ICU nurse Sandra Lindsay, with Long Island Jewish Medical Center in Queens, New York, received the Pfizer-BioNTech COVID-19 vaccine. Food and Drug Administration (FDA) ’ s Vaccines and Related Biological Products Advisory Committee on Thursday, December 17. Both vaccines have demonstrated about 94-95% efficacy in clinical trials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
DECEMBER 28, 2023
Immunosurveillance and the importance of CD4 T cells in developing cancer vaccines The TRACERx data have been used to identify clonal mutations for each patient in the study by comparing a patient’s tumour DNA to their healthy DNA, thereby identifying patient-specific mutations that could be targeted by a range of novel immune therapy modalities.
The Pharma Data
OCTOBER 21, 2020
21, 2020 — Proactive interventions such as asthma self-management education, flu vaccination, and use of spacers with inhalers cut medical costs for low-income children with asthma, according to a study published online Oct. Influenza vaccination was associated with a decreased probability of primary care physician visits (6 to 3.5
The Pharma Data
NOVEMBER 13, 2020
Measles cases saw a steady decline from 2010 to 2016 and reached a historic low in 2016 before progressively climbing to 2019. The report’s authors attribute the increases in cases and deaths to failure of timely vaccination of children. WHO and UNICEF issued an emergency call to action on Nov. ” More Information.
The Pharma Data
JANUARY 4, 2021
King hosted “Larry King Live” on CNN from 1985 until 2010. ” Britain to Try Mix-and-Match COVID-19 Vaccinations. If a second dose of the first COVID-19 vaccine isn’t available or the maker isn’t known, then another vaccine may be used, new British guidelines say, The New York Times reported Sunday.
The Pharma Data
MAY 15, 2023
The vaccine candidate demonstrated non-inferiority in primary endpoints for five Neisseria meningitidis serogroups (A, B, C, W, and Y) compared to two doses of Bexsero (meningococcal group B vaccine) and one dose of Menveo (meningococcal group A, C, W-135, and Y conjugate vaccine) in 10–25-year-olds.
Expert insights. Personalized for you.
126 
Let's personalize your content